Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Feb 15, 2011; 3(2): 24-32
Published online Feb 15, 2011. doi: 10.4251/wjgo.v3.i2.24
Published online Feb 15, 2011. doi: 10.4251/wjgo.v3.i2.24
Case | Age (yr) | Sex | Hp | Site | Stage | Therapy | Follow-up data |
1 | 60 | F | + | Stomach | IE | Surg | CR |
2 | 40 | M | + | Stomach | II | Surg + RT | CR |
3 | 50 | M | + | Stomach | II | Surg + RT | CR |
4 | 52 | M | + | Stomach | IE | Surg | CR |
5 | 42 | M | + | Stomach | IE | Surg | CR |
6 | 46 | M | + | Small intestine | IE | Surg | Relapse in stomach 1 year after initial diagnosis, with PR and SD after (recurrent) therapy (surg, RT, CT, Hp eradication) |
7 | 52 | M | - | Stomach | IE | Surg | Relapse in lung 8 years after initial diagnosis with CR after secondary treatment (CT) |
- Citation: Sagaert X, Maes B, Vanhentenrijk V, Baens M, Cutsem EV, Hertogh GD, Geboes K, Tousseyn T. T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the VH gene mutation status. World J Gastrointest Oncol 2011; 3(2): 24-32
- URL: https://www.wjgnet.com/1948-5204/full/v3/i2/24.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v3.i2.24